Back
Rate this talk
Your peers have not rated this talk yet.
1-minute watch | Talk 7 of 7

EHA: Managing R/R adult ALL in the CAR T era

Summary and close

Prof. Max Topp
SYMPOSIUM
EHA

Prof. Max Topp
University Hospital Würzburg, Würzburg, Germany

Prof. Max Topp, University Hospital Würzburg, Würzburg, Germany, summarises the key takeaways from case studies discussed on CAR T treatment aproaches in R/R adult ALL

Read more

Talks in this series

Prof. Max Topp, Dr Bijal Shah and Dr Florence Rabian present at EHA (Managing R_R adult ALL in the CAR T era)
1-minute watch | Talk 1 of 7
EHA: Managing R/R adult ALL in the CAR T era
Series trailer
Prof. Max Topp, Dr Bijal Shah and Dr Florence Rabian present at EHA (Managing R_R adult ALL in the CAR T era)
1-minute watch
EHA: Managing R/R adult ALL in the CAR T era

Series trailer

Prof. Max Topp presents at EHA (Managing R_R adult ALL in the CAR T era)
3-minute watch | Talk 2 of 7
Introduction
Prof. Max Topp
Prof. Max Topp presents at EHA (Managing R_R adult ALL in the CAR T era)
3-minute watch

Introduction

Prof. Max Topp

Dr Bijal Shah presents at EHA (Managing R_R adult ALL in the CAR T era)
13-minute watch | Talk 3 of 7
Understanding the role of CAR T in R/R adult ALL
Dr Bijal Shah
Dr Bijal Shah presents at EHA (Managing R_R adult ALL in the CAR T era)
13-minute watch

Understanding the role of CAR T in R/R adult ALL

Dr Bijal Shah

Dr Florence Rabian presents at EHA (Managing R_R adult ALL in the CAR T era)
4-minute watch | Talk 4 of 7
Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 1
Dr Florence Rabian
Dr Florence Rabian presents at EHA (Managing R_R adult ALL in the CAR T era)
4-minute watch

Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 1

Dr Florence Rabian

Dr Florence Rabian presents at EHA (Managing R_R adult ALL in the CAR T era)
4-minute watch | Talk 5 of 7
Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 2
Dr Florence Rabian
Dr Florence Rabian presents at EHA (Managing R_R adult ALL in the CAR T era)
4-minute watch

Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 2

Dr Florence Rabian

Dr Bijal Shah presents at EHA (Managing R_R adult ALL in the CAR T era)
6-minute watch | Talk 6 of 7
Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 3
Dr Bijal Shah
Dr Bijal Shah presents at EHA (Managing R_R adult ALL in the CAR T era)
6-minute watch

Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 3

Dr Bijal Shah

Prof. Max Topp presents at EHA (Managing R_R adult ALL in the CAR T era)
1-minute watch | Talk 7 of 7
Summary and close
Prof. Max Topp
Prof. Max Topp presents at EHA (Managing R_R adult ALL in the CAR T era)
1-minute watch

Summary and close

Prof. Max Topp

Prof. Max Topp, Dr Bijal Shah and Dr Florence Rabian present at EHA (Managing R_R adult ALL in the CAR T era)
1-minute watch | Talk 1 of 7
EHA: Managing R/R adult ALL in the CAR T era
Series trailer
Prof. Max Topp, Dr Bijal Shah and Dr Florence Rabian present at EHA (Managing R_R adult ALL in the CAR T era)
1-minute watch
EHA: Managing R/R adult ALL in the CAR T era

Series trailer

Prof. Max Topp presents at EHA (Managing R_R adult ALL in the CAR T era)
3-minute watch | Talk 2 of 7
Introduction
Prof. Max Topp
Prof. Max Topp presents at EHA (Managing R_R adult ALL in the CAR T era)
3-minute watch

Introduction

Prof. Max Topp

Dr Bijal Shah presents at EHA (Managing R_R adult ALL in the CAR T era)
13-minute watch | Talk 3 of 7
Understanding the role of CAR T in R/R adult ALL
Dr Bijal Shah
Dr Bijal Shah presents at EHA (Managing R_R adult ALL in the CAR T era)
13-minute watch

Understanding the role of CAR T in R/R adult ALL

Dr Bijal Shah

Dr Florence Rabian presents at EHA (Managing R_R adult ALL in the CAR T era)
4-minute watch | Talk 4 of 7
Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 1
Dr Florence Rabian
Dr Florence Rabian presents at EHA (Managing R_R adult ALL in the CAR T era)
4-minute watch

Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 1

Dr Florence Rabian

Dr Florence Rabian presents at EHA (Managing R_R adult ALL in the CAR T era)
4-minute watch | Talk 5 of 7
Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 2
Dr Florence Rabian
Dr Florence Rabian presents at EHA (Managing R_R adult ALL in the CAR T era)
4-minute watch

Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 2

Dr Florence Rabian

Dr Bijal Shah presents at EHA (Managing R_R adult ALL in the CAR T era)
6-minute watch | Talk 6 of 7
Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 3
Dr Bijal Shah
Dr Bijal Shah presents at EHA (Managing R_R adult ALL in the CAR T era)
6-minute watch

Expert perspectives: Exploring CAR T treatment approaches in R/R adult ALL – Case study 3

Dr Bijal Shah

Prof. Max Topp presents at EHA (Managing R_R adult ALL in the CAR T era)
1-minute watch | Talk 7 of 7
Summary and close
Prof. Max Topp
Prof. Max Topp presents at EHA (Managing R_R adult ALL in the CAR T era)
1-minute watch

Summary and close

Prof. Max Topp

Interested in this topic?

Find more like this

Suggested for you

Explore suggested content tailored to your role within the CAR T-cell therapy journey

Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.